The global intramuscular vaccine adjuvants market is estimated to be valued at US$ 650.6 million in 2022 and is expected to exhibit a CAGR of 6.7% over the forecast period of 2023-2030,
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |